Integrated Wealth Management (Palm Desert)’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$237K Sell
3,554
-62
-2% -$4.13K 0.08% 219
2016
Q4
$236K Buy
3,616
+550
+18% +$35.7K 0.09% 208
2016
Q3
$217K Sell
3,066
-1,033
-25% -$75.3K 0.08% 207
2016
Q2
$303K Buy
4,099
+238
+6% +$16.4K 0.12% 161
2016
Q1
$251K Buy
3,861
+285
+8% +$19.4K 0.11% 161
2015
Q4
$276K Sell
3,576
-213
-6% -$16.9K 0.12% 137
2015
Q3
$312K Sell
3,789
-928
-20% -$82.6K 0.14% 134
2015
Q2
$416K Buy
4,717
+111
+2% +$10.2K 0.16% 116
2015
Q1
$406K Buy
+4,606
New +$409K 0.17% 111

Other funds holding NVS

Integrated Wealth Management (Palm Desert)'s NVS Position: Q1 2017 in Review

Integrated Wealth Management (Palm Desert) reduced its Novartis (NVS) stake by 1.7% in Q1 2017, selling an estimated $4.13K and leaving 3,554 shares worth $237K. The position accounts for 0.08% of the portfolio, ranked #219.

Integrated Wealth Management (Palm Desert) first reported a position in NVS in Q1 2015 and has held it in 9 quarters since. The position peaked at $416K in Q2 2015. 910 funds tracked by Wall St. Rank hold NVS as of Q1 2017.

  • Integrated Wealth Management (Palm Desert) held 3,554 shares of Novartis worth $237K as of Q1 2017.
  • Integrated Wealth Management (Palm Desert) sold 62 Novartis shares in Q1 2017, an estimated $4.13K.
  • Novartis made up 0.08% of Integrated Wealth Management (Palm Desert)'s portfolio in Q1 2017, its #219 holding.
  • Integrated Wealth Management (Palm Desert) first reported a position in Novartis in Q1 2015 and has held it in 9 quarters since.
  • Integrated Wealth Management (Palm Desert)'s Novartis position peaked at $416K in Q2 2015.
  • 910 funds tracked by Wall St. Rank held Novartis as of Q1 2017.

Based on Integrated Wealth Management (Palm Desert)'s 13F filing for Q1 2017, filed 14 Apr 2017.